Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients.

ABSTRACT: The clinical consequences of untreated, severe anemia in patients with nondialysis CKD can be significant, but disparities exist in the anemia treatment guidelines and position papers issued from working groups and associations across the world. These differ in hemoglobin target and iron levels and their emphasis on various iron markers and other clinical outcomes. Not surprisingly, disparities are observed in anemia treatment strategies among patients with nondialysis CKD across different areas of the world. Over the past decade, the prescription and dosage of both iron therapies and erythropoiesis-stimulating agents have shifted, with notable regional differences observed. Moreover, there is ongoing debate regarding oral versus intravenous administration of iron. Compared with oral iron

SUBMITTER: Locatelli F 

PROVIDER: S-EPMC4934828 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature